/TRUE.CN

TRUE.CN Stock - Treatment.Com International Inc.

Q: What is the analyst price target for TRUE.CN?

Analyst price target information is not currently available for TRUE.CN.

Q: What is TRUE.CN's market cap?

Market capitalization information is not currently available for TRUE.CN.

Healthcare|Medical - Healthcare Information Services|CNQ

$0.51-1.92%

$0.01 (-1.92%) • Aug 20

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.56

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for TRUE.CN

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.43

52W High$0.85

52W Low$0.33

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$10,990	N/A	N/A	N/A	N/A
Gross Profit	$10,990	N/A	$-377,281	$-656,401	$-326,853
Gross Margin	100.0%	N/A	N/A	N/A	N/A
Operating Income	$-6,056,715	$-2,326,930	$-3,840,628	$-13,919,921	$-2,908,268
Net Income	$-7,553,593	$-3,722,382	$-3,699,493	$-13,841,197	$-2,908,268
Net Margin	-68731.5%	N/A	N/A	N/A	N/A
EPS	$-0.17	$-0.26	$-0.60	$-2.14	$-0.45

Company Overview

Treatment.Com International Inc. provides personalized health care information services in Canada. It also develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. The company offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Treatment.Com International Inc. was incorporated in 2018 and is headquartered in Vancouver, Canada.

Visit Website

Earnings History & Surprises

TRUE.CN

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.12

Q3 2023

EPS Surprise History

Q1 23

No data

Q2 23

No data

Q3 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2023	Sep 30, 2023	—	$-0.12	—	—
Q2 2023	Jun 30, 2023	—	$-0.04	—	—
Q1 2023	Mar 31, 2023	—	$-0.01	—	—

Frequently Asked Questions about TRUE.CN

What is TRUE.CN's current stock price?

Treatment.Com International Inc. (TRUE.CN) is currently trading at $0.51 per share. The stock has moved -1.92% today.

What is the analyst price target for TRUE.CN?

No analyst price targets are currently available for this stock.

What sector is Treatment.Com International Inc. in?

Treatment.Com International Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the CNQ exchange.

What is TRUE.CN's market cap?

Treatment.Com International Inc. has a market capitalization of $0.04 billion, making it a small-cap company.

Does TRUE.CN pay dividends?

No, Treatment.Com International Inc. does not currently pay a dividend to shareholders.